Madrigal Pharmaceuticals Inc (MDGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 237,684 | 499,597 | 622,517 | 99,915 | 62,055 |
| Marketable Securities | 765,943 | 563,197 | 436,546 | 534,216 | 170,296 |
| Receivables | 30,463 | 6,899 | N/A | N/A | N/A |
| Inventories | 8,715 | 7,072 | 854 | N/A | N/A |
| TOTAL | $1,063,666 | $1,091,728 | $1,073,952 | $637,281 | $235,469 |
| Non-Current Assets | |||||
| PPE Net | 2,268 | 1,695 | 1,742 | 1,553 | 659 |
| Intangibles | 4,819 | 4,910 | 5,000 | 0 | 0 |
| Other Non-Current Assets | 2,512 | 1,456 | 1,586 | 1,713 | 1,836 |
| TOTAL | $9,599 | $8,061 | $8,328 | $3,266 | $2,495 |
| Total Assets | $1,073,265 | $1,099,789 | $1,082,280 | $640,547 | $237,964 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 45,966 | 8,994 | 21,528 | 28,041 | 16,542 |
| Accrued Expenses | 131,003 | 115,611 | 92,271 | 89,980 | 82,610 |
| TOTAL | $177,847 | $125,162 | $114,341 | $118,548 | $99,665 |
| Non-Current Liabilities | |||||
| Long Term Debt | 117,087 | 116,607 | 116,135 | 115,480 | 114,727 |
| Other Non-Current Liabilities | 1,176 | 900 | 1,045 | 1,186 | 1,323 |
| TOTAL | $118,263 | $117,507 | $117,180 | $116,666 | $116,050 |
| Total Liabilities | $296,110 | $242,669 | $231,521 | $235,214 | $215,715 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 21,810 | 21,713 | 21,312 | 19,897 | 19,743 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | -1,742,766 | -1,635,802 | -1,483,831 | -1,336,290 | -1,224,096 |
| Other shareholders' equity | 1,271 | -368 | -172 | 468 | -42 |
| TOTAL | $777,155 | $857,120 | $850,759 | $405,333 | $22,249 |
| Total Liabilities And Equity | $1,073,265 | $1,099,789 | $1,082,280 | $640,547 | $237,964 |